Search hospitals > Colorado > Colorado Springs
UCHealth Memorial Hospital Central
Claim this profileColorado Springs, Colorado 80909
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
186 reported clinical trials
29 medical researchers
Summary
UCHealth Memorial Hospital Central is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. UCHealth Memorial Hospital Central is involved with conducting 186 clinical trials across 325 conditions. There are 29 research doctors associated with this hospital, such as Bradley R. Corr, Robert Hoyer, MD, Jose M. Pacheco, and Breelyn Wilky, M.D..Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Bradley R. CorrUniversity of Colorado Hospital2 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
21 reported clinical trials
33 drugs studied
Robert Hoyer, MDUCHealth Memorial Hospital Central2 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
19 reported clinical trials
33 drugs studied
Jose M. PachecoUniversity of Colorado Hospital5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
30 drugs studied
Breelyn Wilky, M.D.University of Colorado2 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Cancer
17 reported clinical trials
28 drugs studied
Clinical Trials running at UCHealth Memorial Hospital Central
Lung Cancer
Breast Cancer
Prostate Cancer
Esophageal cancer
Ovarian Cancer
Breast cancer
Non-Small Cell Lung Cancer
Testicular cancer
Small Cell Lung Cancer
Laryngeal Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UCHealth Memorial Hospital Central?
UCHealth Memorial Hospital Central is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. UCHealth Memorial Hospital Central is involved with conducting 186 clinical trials across 325 conditions. There are 29 research doctors associated with this hospital, such as Bradley R. Corr, Robert Hoyer, MD, Jose M. Pacheco, and Breelyn Wilky, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.